OpenCharities

This text was generated using OCR and may contain errors. Check the original PDF to see the document submitted to the regulator.

2024-03-31-accounts

Company no. 04862177 Charity no. 1100518

Transform Drug Policy Foundation Report and Unaudited Financial Statements

31 March 2024

Transform Drug Policy Foundation

Reference and administrative details

For the year ended 31 March 2024

Company number 04862177
Charity number 1100518
Registered office and The Station
operational address Silver Street
Bristol
BS1 2AG
Trustees Trustees, who are also directors under company law, who served
during the year and up to the date of this report were as follows:
Victoria Beere Appointed 2 September 2024
Courtney Brown Appointed 2 September 2024
Karl Burnett Appointed 2 September 2024
Nina Edmonds
Katrina Ffrench Resigned 19 June 2024
Nadia Islam Appointed 4 May 2023
Resigned 29 April 2024
Jay Jackson Appointed 4 May 2023
Rebecca Kelly Appointed 2 September 2024
Jason Kew Appointed 4 May 2023
Rowan Miller
Catherine Murphy Appointed 2 September 2024
Mark Robinson Appointed 31 October 2024
Hannah Slater Resigned 22 September 2023
Victoria Unwin
Chief Executive Officer Alex Feis-Bryce To 31 January 2024
Jane Slater Interim CEO from 1 February 2024
Co-CEO from 1 April 2024
Shoba Ram Co-CEO from 1 April 2024
Bankers Triodos Bank The Co-operative Bank
Deanery Road PO Box 250
Bristol Skelmersdale
BS1 5AS WN8 6WT
Independent Godfrey Wilson Limited
examiners Chartered accountants and statutory auditors
5th Floor Mariner House
62 Prince Street
Bristol
BS1 4QD

1

Transform Drug Policy Foundation

Report of the trustees

For the year ended 31 March 2024

The trustees present their report and accounts for the year ended 31 March 2024. Reference and administrative information set out on page 1 forms part of this report. The financial statements comply with current statutory requirements, the Memorandum and Articles of Association and the Statement of Recommended Practice - Accounting and Reporting by Charities (effective from January 2019).

Objectives and activities for the public benefit

The trustees have had regard to the guidance issued by the Charity Commission on public benefit.

The charity's activities during the year were the advancement of the education of the public and organisations in drug policy by research and dissemination of information, with a view to increasing the effectiveness of such policy and to preserve and safeguard the interests of the public. All our work is driven by the need to improve policy so that it better protects people according to reputable evidence.

Chair's report

Sadly, Hannah Slater, our Chair, had to resign due to ill-health in September 2023, and Vicky Unwin was unanimously elected by the Board to replace her. In addition, we are continuously seeking to refresh the Board of Trustees, bringing on new and diverse members to better represent the communities we work with, and we remain committed to increasing our diversity within the team as well. We also lost our CEO, Alex Feis-Bryce, and we convey our grateful thanks for his short but successful tenure with Transform.

Key achievements over the past year

Transform remains a key driver behind cannabis legalisation and regulation. We have worked with officials in Malta, Luxembourg, the Netherlands, Canada, Uruguay and Czechia on cannabis reforms, informed by our practical guide for regulation. With demand growing for our insight, our guide has been translated into Spanish, Portuguese, German and Czech.

Anyone’s Child has continued to influence the national conversation around drugs through our ‘Take Drugs Seriously’ series of public events, which bring together local communities, police, councils and health professionals for grown-up conversations about drug policy. We know that these events are catalysts for localities to consider and implement alternative approaches to drug policy, enabling them to push forward reforms despite the confines of UK law. These nascent changes further demonstrate the effectiveness of our incredible network of Anyone’s Child families and activists - this group of people with lived experience of the harms of UK drugs policy are central to the call for change.

Once again, we had a successful lobby of Parliament on 27 June 2023 with Anyone’s Child families and activists joined by 150 people on the day. MPs from across the political spectrum addressed our supporters outside Westminster and we held a packed event in the House of Commons to attract new MPs to our cause.

We were also delighted to launch our new publication ‘How to Regulate Psychedelics: A practical guide’ in which we have set out recommendations for establishing a just and effective system of legal regulation, addressing challenging questions in the debate including minimising corporate capture, ensuring equity, protecting indigenous rights, tackling psychedelic exceptionalist and interactions with international treaty law. Using these policy proposals, we will be focusing on advocacy work around psychedelics regulation - the new frontier for drug reform.

2

Transform Drug Policy Foundation

Report of the trustees

For the year ended 31 March 2024

We successfully delivered various project work during the financial year, including with the University of Bristol’s Brigstow Institute. Part of this work was to host workshops and write an ethics report on drug-related research. This report has now been accepted by the University of Bristol as their ethics policy and we are looking to extend this out to all UK universities, if not further afield.

We also launched a documentary film with our Blaksox allyship about our joint visit to New York to study how the legal regulation of cannabis has been working, and to see what lessons we could learn for our proposed blueprint for the UK.

We continue to work towards our vision of a world where drug policy ensures safer and healthier communities. Next year we will be launching a major campaign to legalise cannabis, and demonstrate how this would ease pressure on prisons, the police, the NHS and contribute valuable tax revenues to the exchequer. Watch this space!

We give our thanks to Transform’s funders and donors who continue to support our work in these uncertain times, along with our activists, volunteers and supporters. While our mission is ambitious, we remain committed to our vision of a world where drug policy protects people from harm. This year we were delighted to see indications of progress on this path, and to play our own part in bringing about change.

Financial review

During the year we maintained our funding base via individual donations and continued funding from trusts and foundations. However our income was lower than in previous years due to a number of long-term grants from trust funders coming to a natural end. We are committed to focusing on fundraising and reducing our expenditure over the next financial year to ensure that we build a diverse and sustainable funding base for the future.

Results

The results are shown on the Income and Expenditure Account.

Volunteers

During the year volunteers donated their services to the charity. The trustees estimate that these services in kind had a value of the order of £6,300.

Funders

Funds are received via grant-making trusts and from donations made by a wide range of individuals in the form of monthly direct debits, one-off payments, gifts in kind and larger donations made annually or several times a year. Donations are also collected at special events.

Reserves policy

The trustees have examined the charity’s requirements for reserves in light of the main risks to the organisation. It has established a policy whereby a designated fund should be established to meet: the working capital requirements of the charity for a period of 3 months in case future grants are not forthcoming; statutory payments liabilities for all staff; other liabilities. An amount of £84,900 has been maintained from unrestricted funds for this purpose, held in cash at the bank. Full details are set out in our Reserves and Investment Policy.

3

Transform Drug Policy Foundation

Report of the trustees

For the year ended 31 March 2024

Structure, governance and management Governing document

Transform Drug Policy Foundation is a charitable company limited by guarantee (company number 04862177) and registered as a charity (charity number 1100518). The company was established under a Memorandum of Association and is governed by its Articles of Association. In the event of the company being wound up members are required to contribute an amount not exceeding £1. Its registered office is The Station, Silver Street, Bristol, BS1 2AG.

Risk management and assessment

The trustees are aware of their responsibilities to conduct a thorough risk assessment of the charity’s activities.

Currently risks are identified and controlled through a process of management overview of financial, managerial and strategic issues, coupled with frequent staff discussion and maintained in a risk register.

Appointment of trustees

The trustees who are directors for the purpose of company law and trustees for the purpose of charity law, who served for the year and up to the date of this report are set out on page 1. New trustees are appointed upon the recommendation of existing trustees and may involve external recruitment efforts using pro bono professional advice.

Organisational structure

Day to day responsibility for the provision of services rests with the Chief Executive Officer. Alex FeisBryce resigned from the role in January 2024 and the Deputy CEO, Jane Slater, was appointed as Interim CEO from February 2024.

Statement of responsibilities of the trustees

The trustees (who are also directors of the charity for the purposes of company law) are responsible for preparing the trustees' report and the financial statements in accordance with applicable law and United Kingdom Accounting Standards, including Financial Reporting Standard 102: The Financial Reporting Standard applicable in the UK and Republic of Ireland (United Kingdom Generally Accepted Accounting Practice).

Company law requires the trustees to prepare financial statements for each financial year, which give a true and fair view of the state of affairs of the charity and of the income and expenditure of the charity for that period. In preparing those financial statements the trustees are required to:

4

Transform Drug Policy Foundation

Report of the trustees

For the year ended 31 March 2024

The trustees are responsible for keeping proper accounting records which disclose with reasonable accuracy at any time the financial position of the charity and which enable them to ensure that the financial statements comply with the Companies Act 2006. The trustees are also responsible for safeguarding the assets of the charity and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

The trustees confirm that to the best of their knowledge there is no information relevant to the examination of which the independent examiners are unaware. The trustees also confirm that they have taken all necessary steps to ensure that they themselves are aware of all relevant examination information and that this information has been communicated to the independent examiners.

Members of the charity guarantee to contribute an amount not exceeding £1 to the assets of the charity in the event of winding up. The trustees are members of the charity but this entitles them only to voting rights. The trustees have no beneficial interest in the charity.

Independent examiners

Godfrey Wilson Limited were re-appointed as independent examiners to the charitable company during the year and have expressed their willingness to continue in that capacity.

Approved by the trustees on 4 December 2024 and signed on their behalf by

Vicky Unwin

Victoria Unwin - Chair

5

Independent examiner's report

To the trustees of

Transform Drug Policy Foundation

I report to the trustees on my examination of the accounts of Transform Drug Policy Foundation (the charitable company) for the year ended 31 March 2024, which are set out on pages 7 to 18.

Responsibilities and basis of report

As the trustees of the charitable company (and also its directors for the purposes of company law) you are responsible for the preparation of the accounts in accordance with the requirements of the Companies Act 2006 (‘the 2006 Act’).

Having satisfied myself that the accounts of the charitable company are not required to be audited under Part 16 of the 2006 Act and are eligible for independent examination, I report in respect of my examination of the charitable company's accounts as carried out under section 145 of the Charities Act 2011 (‘the 2011 Act’). In carrying out my examination I have followed the Directions given by the Charity Commission under section 145(5) (b) of the 2011 Act.

Independent examiner’s statement

I have completed my examination. I confirm that no material matters have come to my attention in connection with the examination giving me cause to believe that in any material respect:

I have no concerns and have come across no other matters in connection with the examination to which attention should be drawn in this report in order to enable a proper understanding of the accounts to be reached.

Dougal Howard

Date: 9 December 2024 Dougal Howard ACA Member of the ICAEW For and on behalf of: Godfrey Wilson Limited Chartered accountants and statutory auditors 5th Floor Mariner House 62 Prince Street Bristol BS1 4QD

6

Transform Drug Policy Foundation

Statement of financial activities (incorporating an income and expenditure account)

For the year ended 31 March 2024

Restricted
Note
£
Income from:
Donations
3
104,531
Charitable activities
4
-
Investments
-
Total income
104,531
Expenditure on:
Raising funds
-
Charitable activities
123,145
Total expenditure
5
123,145
Net income / (expenditure)
and net movement in funds
6
(18,614)
Reconciliation of funds:
Total funds brought forward
50,713
Total funds carried forward
32,099		 Unrestricted
£
111,204
14,201
3,010
128,415
11,496
249,629
261,125
(132,710)
333,087
200,377		 2024
Total
£
215,735
14,201
3,010
232,946
11,496
372,774
384,270
(151,324)
383,800
232,476		 2023
Total
£
358,491
3,976
751
363,218
12,740
401,648
414,388
(51,170)
434,970
383,800

All of the above results are derived from continuing activities. There were no other recognised gains or losses other than those stated above. Movements in funds are disclosed in note 12 to the accounts.

7

Transform Drug Policy Foundation

Balance sheet

As at 31 March 2024

Note
Current assets
Debtors
9
Cash at bank and in hand
Liabilities
Creditors: amounts falling due within 1 year
10
Net current assets
Net assets
11
Funds
12
Restricted funds
Unrestricted funds
Designated funds
General funds
Total charity funds		 £
4,160
242,740		 2024
£
246,900
(14,424)
232,476
232,476
32,099
84,900
115,477
232,476		 2023
£
5,028
395,458
400,486
(16,686)
383,800
383,800
50,713
321,302
11,785
383,800

The directors are satisfied that the company is entitled to exemption from the provisions of the Companies Act 2006 (the Act) relating to the audit of the financial statements for the year by virtue of section 477(2), and that no member or members have requested an audit pursuant to section 476 of the Act.

The directors acknowledge their responsibilities for:

These accounts have been prepared in accordance with the special provisions applicable to companies subject to the small companies' regime.

Approved by the trustees on 4 December 2024 and signed on their behalf by

Vicky Unwin

Victoria Unwin - Chair

8

Transform Drug Policy Foundation

Notes to the financial statements

For the year ended 31 March 2024

1. Accounting policies

a) Basis of preparation

Transform Drug Policy Foundation is a charitable company limited by guarantee registered in England and Wales. The registered office addres is The Station, Silver Street, Bristol, BS1 2AG.

The financial statements have been prepared in accordance with Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities in preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) (effective 1 January 2019) - (Charities SORP (FRS 102)), the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) and the Companies Act 2006.

Transform Drug Policy Foundation meets the definition of a public benefit entity under FRS 102. Assets and liabilities are initially recognised at historical cost or transaction value unless otherwise stated in the relevant accounting policy note.

b) Going concern basis of accounting

The accounts have been prepared on the assumption that the charity is able to continue as a going concern, which the trustees consider appropriate having regard to the current level of unrestricted reserves. There are no material uncertainties about the charity's ability to continue as a going concern.

c) Income

Income is recognised when the charity has entitlement to the funds, any performance conditions attached to the item of income have been met, it is probable that the income will be received and the amount can be measured reliably.

Income from the government and other grants, whether 'capital' grants or 'revenue' grants, is recognised when the charity has entitlement to the funds, any performance conditions attached to the grants have been met, it is probable that the income will be received and the amount can be measured reliably and is not deferred.

d) Donated services and facilities

Donated professional services and donated facilities are recognised as income when the charity has control over the item, any conditions associated with the donated item have been met, the receipt of economic benefit from the use by the charity of the item, is probable and the economic benefit can be measured reliably. In accordance with the Charities SORP (FRS 102), general volunteer time is not recognised.

On receipt, donated professional services and donated facilities are recognised on the basis of the value of the gift to the charity which is the amount the charity would have been willing to pay to obtain services or facilities of equivalent economic benefit on the open market; a corresponding amount is then recognised in expenditure in the period of receipt.

e) Interest receivable

Interest on funds held on deposit is included when receivable and the amount can be measured reliably by the charity: this is normally upon notification of the interest paid or payable by the bank.

9

Transform Drug Policy Foundation

Notes to the financial statements

For the year ended 31 March 2024

1. Accounting policies (continued)

f) Funds accounting

g) Expenditure and irrecoverable VAT

Expenditure is recognised once there is a legal or constructive obligation to make a payment to a third party, it is probable that settlement will be required and the amount of the obligation can be measured reliably.

Irrecoverable VAT is charged as a cost against the activity for which the expenditure was incurred.

h) Allocation of support and governance costs

Support and governance costs are those functions that assist the work of the charity but do not directly undertake charitable activities. These costs have been allocated in full to expenditure on charitable activities which is deemed to be reflective of the activities of the charity in this period.

i) Debtors

Trade and other debtors are recognised at the settlement amount due after any trade discount offered. Prepayments are valued at the amount prepaid net of any trade discounts due.

j) Cash at bank and in hand

Cash at bank and cash in hand includes cash and short term highly liquid investments with a short maturity of three months or less from the date of acquisition or opening of the deposit or similar account.

k) Creditors

Creditors and provisions are recognised where the charity has a present obligation resulting from a past event that will probably result in the transfer of funds to a third party and the amount due to settle the obligation can be measured or estimated reliably. Creditors and provisions are normally recognised at their settlement amount after allowing for any trade discounts due.

l) Financial instruments

The charitable company only has financial assets and financial liabilities of a kind that qualify as basic financial instruments. Basic financial instruments are initially recognised at transaction value and subsequently measured at their settlement value with the exception of bank loans which are subsequently recognised at amortised cost using the effective interest method.

m) Pension costs

The company operates a defined contribution pension scheme for its employees. There are no further liabilities other than that already recognised in the SOFA.

n) Foreign currency transactions

Transactions in foreign currencies are translated at rates prevailing at the date of the transaction. Balances denominated in foreign currencies are translated at the rate of exchange prevailing at the year end.

10

Transform Drug Policy Foundation

Notes to the financial statements

For the year ended 31 March 2024

1. Accounting policies (continued)

o) Accounting estimates and key judgements

The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised if the revision affects only that period, or in the period of the revision and future periods if the revision affects both current and future periods.

There were no sources of estimation uncertainty that have a significant effect on the amounts recognised in the financial statements during the year.

2. Prior period comparatives: statement of financial activities

Income from:
Donations and legacies
Charitable activities
Investments
Total income
Expenditure on:
Raising funds
Charitable activities
Total expenditure
Net income / (expenditure)
and net movement in funds		 Restricted
£
£
91,827
266,664
-
3,976
-
751
91,827
271,391
-
12,740
116,007
285,641
116,007
298,381
(24,180)
(26,990)
Unrestricted		 2023
Total
£
358,491
3,976
751
363,218
12,740
401,648
414,388
(51,170)

11

Transform Drug Policy Foundation

Notes to the financial statements

For the year ended 31 March 2024

3. Income from donations

Grants
AB Charitable Trust
Brigstow Institute
Glass House Trust
John Ellerman Foundation
Linnet Trust
Orr Mackintosh Foundation
Tudor Trust
University of Bristol
Donations
Gifts in kind
Other donations
Total from donations*		 Restricted
£
£
-
20,000
13,006
-
-
15,000
40,000
-
-
10,000
-
30,000
50,000
-
1,525
-
-
8,000
-
28,204
104,531
111,204
Unrestricted		 2024
Total
£
20,000
13,006
15,000
40,000
10,000
30,000
50,000
1,525
8,000
28,204
215,735

*Gifts in kind represents pro bono support related to the charity's website and digital productions.

Prior period comparative

Grants
Brigstow Institute
Esmée Fairbairn Foundation
Glass House Trust
John Ellerman Foundation
OSF Global Fund
Trust for London
University of Bristol
Donations
Other donations
Total from donations		 2023
Restricted
Total
£
£
£
902
-
902
-
55,000
55,000
-
1,500
1,500
40,000
-
40,000
-
152,312
152,312
42,000
-
42,000
1,260
-
1,260
7,665
57,852
65,517
91,827
266,664
358,491
Unrestricted

12

Transform Drug Policy Foundation

Notes to the financial statements

For the year ended 31 March 2024

4. Income from charitable activities

Income from charitable activities
Consultancy
Event income
Sales of merchandise
Total income from charitable activities		 2024
Total
£
13,781
85
335
14,201		 2023
Total
£
3,300
676
-
3,976

All income from charitable activities in the current and prior year was unrestricted.

5. Total expenditure

Staff costs (note 7)
Training and recruitment
Postage and stationery
Printing and design
Subscriptions, licences and charges
Travel and subsistence
Event costs
Digital productions
Equipment and software
Legal and professional
Office costs
Rent, rates and utilities
Insurance
Accountancy
Bank charges
Sub-total
Allocation of support and governance
costs
Total expenditure		 Raising
funds
£
11,496
-
-
-
-
-
-
-
-
-
-
-
-
-
-
11,496
-
11,496		 Charitable
activities
£
250,313
1,195
-
2,208
-
2,955
32,142
10,368
-
18,099
-
-
-
-
-
317,280
55,494
372,774		 £
19,593
-
1,441
-
3,590
-
-
-
3,813
-
4,561
8,004
1,635
12,596
261
55,494
(55,494)
-
Support and
governance
costs		 2024 Total
£
281,402
1,195
1,441
2,208
3,590
2,955
32,142
10,368
3,813
18,099
4,561
8,004
1,635
12,596
261
384,270
-
384,270

Total governance costs were £2,160 (2023: £1,980).

13

Transform Drug Policy Foundation

Notes to the financial statements

For the year ended 31 March 2024

5.
Total expenditure (continued)
Prior period comparative
Staff costs (note 7)
Training and recruitment
Postage and stationery
Printing and design
Subscriptions, licences and charges
Travel and subsistence
Event costs
Digital productions
Equipment and software
Legal and professional
Office costs
Rent, rates and utilities
Insurance
Accountancy
Bank charges
Sub-total
Allocation of support and governance
costs
Total expenditure		 Raising
funds
£
12,543
-
-
-
-
-
-
-
-
197
-
-
-
-
-
12,740
-
12,740		 Charitable
activities
£
266,290
1,445
-
4,915
-
3,074
46,965
3,110
-
4,975
-
-
-
-
-
330,774
70,874
401,648		 2023 Total
£
£
20,195
299,028
-
1,445
1,785
1,785
-
4,915
2,940
2,940
-
3,074
-
46,965
-
3,110
5,968
5,968
8,595
13,767
5,702
5,702
11,369
11,369
2,199
2,199
11,827
11,827
294
294
70,874
414,388
(70,874)
-
-
414,388
Support and
governance
costs

14

Transform Drug Policy Foundation

Notes to the financial statements

For the year ended 31 March 2024

6. Net movement in funds

This is stated after charging:

Trustees' remuneration
Trustees' reimbursed expenses
Independent examiner's remuneration:
Independent examination (excluding VAT)		 2024
£
Nil
46
1,800		 2023
£
Nil
Nil
1,650

In common with other charities of our size and nature we use our independent examiners to assist with the preparation of the financial statements.

7. Staff costs and numbers

Staff costs were as follows:

Salaries and wages
Social security costs
Pension costs		 2024
£
249,621
19,800
11,981
281,402		 2023
£
264,132
22,087
12,809
299,028

No employee earned more than £60,000 during the year (2023: one employee earned between £60,000 - £69,999).

The key management personnel of the charitable company comprise the Trustees, the outgoing CEO, and the Interim CEO from 1 February 2024. The total employee benefits of the key management personnel were £68,931 (2023: £70,458).

Average head count 2024
No.
8		 2023
No.
9

8. Taxation

The charity is exempt from corporation tax as all its income is charitable and is applied for charitable purposes.

15

Transform Drug Policy Foundation

Notes to the financial statements

For the year ended 31 March 2024

9. Debtors

Debtors
Prepayments
Other debtors		 2024
£
1,089
3,071
4,160		 2023
£
1,055
3,973
5,028

10. Creditors: amounts due within 1 year

Creditors: amounts due within 1 year
Trade creditors
Accruals
Other taxation and social security
Other creditors		 2024
£
730
7,315
4,203
2,176
14,424		 2023
£
2,347
6,290
6,209
1,840
16,686

11. Analysis of net assets between funds

Current assets
Current liabilities
Net assets at 31 March 2024
Prior year comparative
Current assets
Current liabilities
Net assets at 31 March 2023		 Restricted
funds
£
32,099
-
32,099
Restricted
funds
£
52,373
(1,660)
50,713		 Designated
funds
£
84,900
-
84,900
Designated
funds
£
321,302
-
321,302		 General
funds
£
129,901
(14,424)
115,477
General
funds
£
26,811
(15,026)
11,785		 Total
funds
£
246,900
(14,424)
232,476
Total funds
£
400,486
(16,686)
383,800

16

Transform Drug Policy Foundation

Notes to the financial statements

For the year ended 31 March 2024

12. Movements in funds

Restricted funds
Anyone's Child
Trust for London
University of Bristol
Brigstow Institute
Total restricted funds
Unrestricted funds
Designated funds:
Open Society Foundation
Esmée Fairbairn Foundation
Reserves fund
Trustee donation
Total designated funds
General funds
Total unrestricted funds
Total funds		 At 1 April
2023
£
35,311
15,402
-
-
50,713
152,312
20,004
126,000
22,986
321,302
11,785
333,087
383,800		 Income
£
£
90,000
(93,212)
-
(15,402)
1,525
(1,525)
13,006
(13,006)
104,531
(123,145)
-
(152,312)
-
(20,004)
-
-
-
(22,986)
-
(195,302)
128,415
(65,823)
128,415
(261,125)
232,946
(384,270)
Expenditure		 Transfers
between
funds
£
-
-
-
-
-
-
-
(41,100)
-
(41,100)
41,100
-
-		 At 31
March
2024
£
32,099
-
-
-
32,099
-
-
84,900
-
84,900
115,477
200,377
232,476

Purposes of restricted funds Anyone's Child

The Anyone's Child project, funded by the Tudor Trust and the John Ellerman Foundation, aims to enable families impacted by current drug policy to speak out.

Trust for London

Money received from the Trust for London to supported an allyship between Transform Drug Policy Foundation and Blaksox, which seeks to amplify the voices of Black communities in the drug policy debate.

University of Bristol

This is funding to employ an intern to support Transform and the Anyone's Child campaign.

Brigstow Institute

This funding is to work in partnership with academics from Bristol University to explore how to best tell challenging and sensitive stories around drugs in the city.

Purposes of designated funds Open Society Foundation

The Open Society Foundation provide an annual grant to fund charitable operations, with the current grant running until July 2024.

17

Transform Drug Policy Foundation

Notes to the financial statements

For the year ended 31 March 2024

12. Movements in funds (continued)

Purposes of designated funds (continued)

Esmée Fairbairn Foundation

The Esmée Fairbairn Foundation grant funds the charity's core work in the UK, i.e. education, research and advocacy.

Reserves fund

The reserves fund exists to protect the charity against any sudden unexpected drop in funding. It is calculated to cover three months' running costs, plus the potential cost of staff redundancies and other contractual liabilities in the event of the charity being wound up.

Trustee donation

This donation was designated for some work focusing on Christian Ethics and drug policy reform, including an event at St George’s House and a report.

Prior year comparative
Restricted funds
Anyone's Child
Trust for London
University of Bristol
Brigstow Institute
Total restricted funds
Unrestricted funds
Designated funds:
Open Society Foundation
Esmée Fairbairn Foundation
Reserves fund
Trustee donation
Total designated funds
General funds
Total unrestricted funds
Total funds		 At 1 April
2022
£
74,893
-
-
-
74,893
120,000
16,670
126,000
30,000
292,670
67,407
360,077
434,970		 Income
£
£
47,665
(87,247)
42,000
(26,598)
1,260
(1,260)
902
(902)
91,827
(116,007)
152,312
(120,000)
55,000
(51,666)
-
-
-
(7,014)
207,312
(178,680)
64,079
(119,701)
271,391
(298,381)
363,218
(414,388)
Expenditure		 Transfers
between
funds
£
£
-
35,311
-
15,402
-
-
-
-
-
50,713
-
152,312
-
20,004
-
126,000
-
22,986
-
321,302
-
11,785
-
333,087
-
383,800
At 31 March
2023		 Transfers
between
funds
£
£
-
35,311
-
15,402
-
-
-
-
-
50,713
-
152,312
-
20,004
-
126,000
-
22,986
-
321,302
-
11,785
-
333,087
-
383,800
At 31 March
2023
50,713
152,312
20,004
126,000
22,986
321,302
11,785
333,087
383,800

13. Related party transactions

There were no related party transactions during the current year (2023: £25,000 of unrestricted donations from trustees).

18